Created at Source Raw Value Validated value
May 5, 2022, 11:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Switching immunosuppressive agents from MPA and CNI to low dose prograf (C0 2-4 ng/mL) and mTOR inhibitor 2 weeks before and after BNT162b2.;Remain using MPA and CNI throughout the study;Experimental Drug;Active Comparator Drug;Switching arm;Continue previous regimen", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2460, "treatment_name": "Mycophenolate mofetil+tacrolimus", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2462, "treatment_name": "Mtor inhibitor+tacrolimus", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}]